Molly Lamb
Concepts (394)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Development | 6 | 2025 | 482 | 1.620 |
Why?
| | Muscular Dystrophy, Duchenne | 6 | 2022 | 92 | 1.530 |
Why?
| | Rural Population | 17 | 2025 | 657 | 1.490 |
Why?
| | Head | 2 | 2025 | 120 | 1.470 |
Why?
| | Guatemala | 28 | 2025 | 344 | 1.400 |
Why?
| | Zika Virus Infection | 6 | 2024 | 171 | 1.260 |
Why?
| | Diet | 11 | 2024 | 1270 | 1.220 |
Why?
| | Autoimmunity | 8 | 2020 | 930 | 1.090 |
Why?
| | Islets of Langerhans | 6 | 2014 | 842 | 0.970 |
Why?
| | Zika Virus | 4 | 2024 | 135 | 0.930 |
Why?
| | Dengue | 2 | 2024 | 90 | 0.880 |
Why?
| | Influenza, Human | 7 | 2025 | 618 | 0.830 |
Why?
| | Diabetes Mellitus, Type 1 | 12 | 2020 | 3910 | 0.810 |
Why?
| | Infant | 38 | 2025 | 10023 | 0.770 |
Why?
| | Body Weight | 2 | 2018 | 968 | 0.760 |
Why?
| | Dengue Virus | 2 | 2024 | 59 | 0.760 |
Why?
| | Growth Disorders | 2 | 2023 | 86 | 0.750 |
Why?
| | Body Height | 2 | 2016 | 199 | 0.710 |
Why?
| | Child | 48 | 2025 | 22600 | 0.680 |
Why?
| | Child, Preschool | 38 | 2025 | 11790 | 0.670 |
Why?
| | Infant, Newborn | 18 | 2025 | 6399 | 0.550 |
Why?
| | Microcephaly | 4 | 2024 | 104 | 0.520 |
Why?
| | Child Nutritional Physiological Phenomena | 3 | 2015 | 106 | 0.510 |
Why?
| | Humans | 91 | 2026 | 144667 | 0.500 |
Why?
| | Dietary Carbohydrates | 2 | 2015 | 147 | 0.480 |
Why?
| | Prospective Studies | 18 | 2025 | 7994 | 0.480 |
Why?
| | Pregnenediones | 1 | 2016 | 14 | 0.480 |
Why?
| | Milk | 2 | 2014 | 119 | 0.450 |
Why?
| | HLA-DR Antigens | 2 | 2014 | 220 | 0.450 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 480 | 0.450 |
Why?
| | Carbohydrates | 1 | 2015 | 65 | 0.440 |
Why?
| | Carbonic Anhydrases | 2 | 2005 | 11 | 0.440 |
Why?
| | Prednisone | 1 | 2016 | 221 | 0.440 |
Why?
| | Culicidae | 2 | 2005 | 33 | 0.430 |
Why?
| | Male | 49 | 2025 | 72431 | 0.390 |
Why?
| | Eating | 2 | 2024 | 388 | 0.380 |
Why?
| | Body Mass Index | 8 | 2020 | 2419 | 0.380 |
Why?
| | Oryza | 2 | 2024 | 32 | 0.370 |
Why?
| | Disease Progression | 4 | 2015 | 2847 | 0.370 |
Why?
| | Infant Food | 2 | 2015 | 64 | 0.370 |
Why?
| | Female | 53 | 2025 | 78304 | 0.360 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2025 | 54 | 0.360 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2025 | 138 | 0.360 |
Why?
| | Viruses | 3 | 2023 | 166 | 0.360 |
Why?
| | Developing Countries | 3 | 2025 | 317 | 0.360 |
Why?
| | Cross-Sectional Studies | 10 | 2025 | 5870 | 0.350 |
Why?
| | Sarcoma, Kaposi | 2 | 2023 | 83 | 0.350 |
Why?
| | Cohort Studies | 10 | 2025 | 5957 | 0.350 |
Why?
| | Seroepidemiologic Studies | 5 | 2023 | 171 | 0.350 |
Why?
| | Glucocorticoids | 1 | 2016 | 528 | 0.350 |
Why?
| | Immunoglobulin G | 3 | 2022 | 886 | 0.340 |
Why?
| | Global Health | 2 | 2025 | 401 | 0.340 |
Why?
| | Audiovisual Aids | 1 | 2010 | 11 | 0.330 |
Why?
| | Sexual Maturation | 1 | 2010 | 48 | 0.330 |
Why?
| | Hyperlipidemias | 1 | 2011 | 120 | 0.320 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 93 | 0.320 |
Why?
| | School Teachers | 3 | 2025 | 29 | 0.310 |
Why?
| | Pregnancy | 12 | 2024 | 7122 | 0.310 |
Why?
| | Antibodies, Viral | 6 | 2023 | 672 | 0.300 |
Why?
| | Virus Diseases | 2 | 2022 | 218 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1406 | 0.290 |
Why?
| | Overweight | 3 | 2019 | 606 | 0.290 |
Why?
| | Self Concept | 1 | 2010 | 256 | 0.280 |
Why?
| | Risk Factors | 13 | 2025 | 10796 | 0.280 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2005 | 14 | 0.280 |
Why?
| | Meningitis, Bacterial | 2 | 2022 | 46 | 0.280 |
Why?
| | Glycemic Index | 1 | 2008 | 26 | 0.280 |
Why?
| | Adolescent | 21 | 2025 | 22409 | 0.280 |
Why?
| | Autoantibodies | 5 | 2020 | 1505 | 0.280 |
Why?
| | Delivery, Obstetric | 2 | 2019 | 161 | 0.270 |
Why?
| | Obesity | 5 | 2015 | 3070 | 0.270 |
Why?
| | Caliciviridae Infections | 2 | 2018 | 18 | 0.260 |
Why?
| | Norovirus | 2 | 2018 | 22 | 0.260 |
Why?
| | Respiratory Tract Infections | 2 | 2022 | 395 | 0.260 |
Why?
| | Body Composition | 1 | 2011 | 689 | 0.260 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 6041 | 0.260 |
Why?
| | Viral Vaccines | 2 | 2018 | 107 | 0.250 |
Why?
| | Vaccination | 3 | 2025 | 1419 | 0.250 |
Why?
| | Psychology, Child | 1 | 2007 | 36 | 0.250 |
Why?
| | Caregivers | 3 | 2021 | 1062 | 0.250 |
Why?
| | Lipids | 2 | 2011 | 706 | 0.250 |
Why?
| | Adipose Tissue | 1 | 2011 | 643 | 0.250 |
Why?
| | Gastroenteritis | 2 | 2017 | 63 | 0.250 |
Why?
| | Interviews as Topic | 1 | 2010 | 905 | 0.250 |
Why?
| | Genotype | 4 | 2015 | 1847 | 0.250 |
Why?
| | Herpesvirus 8, Human | 2 | 2023 | 67 | 0.240 |
Why?
| | Adult | 22 | 2025 | 40489 | 0.240 |
Why?
| | Mental Health Services | 2 | 2021 | 472 | 0.230 |
Why?
| | Young Adult | 16 | 2025 | 14122 | 0.230 |
Why?
| | Blood Culture | 1 | 2025 | 25 | 0.220 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2025 | 81 | 0.220 |
Why?
| | Schools | 4 | 2023 | 450 | 0.220 |
Why?
| | Ectoparasitic Infestations | 1 | 2024 | 5 | 0.220 |
Why?
| | Gastrointestinal Tract | 2 | 2019 | 207 | 0.220 |
Why?
| | Masks | 2 | 2022 | 70 | 0.220 |
Why?
| | Animals, Domestic | 1 | 2024 | 17 | 0.220 |
Why?
| | Nasopharynx | 1 | 2025 | 73 | 0.220 |
Why?
| | Digestive System | 1 | 2004 | 29 | 0.210 |
Why?
| | Niacin | 1 | 2024 | 16 | 0.210 |
Why?
| | Income | 1 | 2025 | 201 | 0.200 |
Why?
| | Culex | 1 | 2023 | 14 | 0.200 |
Why?
| | Psychotherapy | 1 | 2025 | 190 | 0.200 |
Why?
| | Educational Personnel | 1 | 2023 | 11 | 0.200 |
Why?
| | Coinfection | 2 | 2022 | 141 | 0.200 |
Why?
| | Saliva | 1 | 2025 | 247 | 0.190 |
Why?
| | Antimicrobial Stewardship | 1 | 2025 | 129 | 0.190 |
Why?
| | HIV Seropositivity | 1 | 2023 | 119 | 0.190 |
Why?
| | Aedes | 1 | 2023 | 65 | 0.190 |
Why?
| | Public Health | 2 | 2026 | 569 | 0.190 |
Why?
| | Bacteremia | 1 | 2025 | 222 | 0.190 |
Why?
| | Metapneumovirus | 1 | 2022 | 15 | 0.180 |
Why?
| | Cross Reactions | 1 | 2022 | 130 | 0.180 |
Why?
| | Diarrhea | 2 | 2023 | 192 | 0.180 |
Why?
| | Cephalometry | 1 | 2022 | 30 | 0.180 |
Why?
| | Anthropometry | 1 | 2022 | 197 | 0.180 |
Why?
| | Erythrocyte Membrane | 2 | 2015 | 54 | 0.170 |
Why?
| | Prevalence | 8 | 2021 | 2839 | 0.170 |
Why?
| | Parents | 3 | 2023 | 1395 | 0.170 |
Why?
| | Family Health | 2 | 2015 | 191 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2024 | 223 | 0.170 |
Why?
| | Sexually Transmitted Diseases, Viral | 1 | 2021 | 11 | 0.170 |
Why?
| | Lead Poisoning | 1 | 2021 | 17 | 0.170 |
Why?
| | Meningitis | 1 | 2022 | 80 | 0.170 |
Why?
| | Pandemics | 3 | 2025 | 1700 | 0.160 |
Why?
| | Health Literacy | 1 | 2023 | 184 | 0.160 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1322 | 0.160 |
Why?
| | Cesarean Section | 2 | 2019 | 227 | 0.160 |
Why?
| | Socioeconomic Factors | 1 | 2025 | 1322 | 0.160 |
Why?
| | Motivation | 1 | 2025 | 601 | 0.160 |
Why?
| | Arsenic | 1 | 2021 | 65 | 0.160 |
Why?
| | Emergency Responders | 1 | 2021 | 37 | 0.160 |
Why?
| | Lysine | 1 | 2022 | 271 | 0.160 |
Why?
| | Midwifery | 1 | 2022 | 66 | 0.160 |
Why?
| | Malaria | 1 | 2021 | 73 | 0.160 |
Why?
| | Birth Intervals | 1 | 2020 | 23 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2015 | 141 | 0.160 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 104 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 835 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2022 | 102 | 0.160 |
Why?
| | Specimen Handling | 1 | 2022 | 187 | 0.160 |
Why?
| | Endpoint Determination | 1 | 2020 | 84 | 0.160 |
Why?
| | Cesarean Section, Repeat | 1 | 2019 | 11 | 0.150 |
Why?
| | Regression Analysis | 1 | 2022 | 998 | 0.150 |
Why?
| | Age of Onset | 4 | 2022 | 551 | 0.150 |
Why?
| | Vaginal Birth after Cesarean | 1 | 2019 | 27 | 0.150 |
Why?
| | Language Tests | 1 | 2019 | 23 | 0.150 |
Why?
| | Refugees | 1 | 2021 | 83 | 0.150 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5414 | 0.150 |
Why?
| | Breast Feeding | 4 | 2015 | 444 | 0.150 |
Why?
| | Population Surveillance | 2 | 2026 | 484 | 0.150 |
Why?
| | Sexual Partners | 1 | 2021 | 192 | 0.150 |
Why?
| | Language Development Disorders | 1 | 2019 | 40 | 0.150 |
Why?
| | Dietary Proteins | 2 | 2013 | 135 | 0.150 |
Why?
| | Motor Skills | 1 | 2020 | 104 | 0.140 |
Why?
| | Adolescent Health | 1 | 2019 | 37 | 0.140 |
Why?
| | Social Class | 2 | 2010 | 265 | 0.140 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2021 | 288 | 0.140 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 29 | 0.140 |
Why?
| | Arbovirus Infections | 1 | 2018 | 20 | 0.140 |
Why?
| | Sensitivity and Specificity | 5 | 2025 | 1995 | 0.140 |
Why?
| | Public Health Surveillance | 1 | 2018 | 83 | 0.140 |
Why?
| | Sexual Behavior | 2 | 2021 | 493 | 0.140 |
Why?
| | HLA-DQ beta-Chains | 2 | 2015 | 57 | 0.140 |
Why?
| | HLA-DR4 Antigen | 2 | 2015 | 74 | 0.140 |
Why?
| | Linear Models | 3 | 2023 | 845 | 0.140 |
Why?
| | HLA-DR3 Antigen | 2 | 2015 | 76 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 431 | 0.140 |
Why?
| | Vaccines | 1 | 2023 | 388 | 0.130 |
Why?
| | Epilepsy | 1 | 2022 | 386 | 0.130 |
Why?
| | Sentinel Surveillance | 1 | 2017 | 46 | 0.130 |
Why?
| | Emergency Service, Hospital | 4 | 2022 | 2325 | 0.130 |
Why?
| | Medicaid | 1 | 2021 | 464 | 0.130 |
Why?
| | Celiac Disease | 1 | 2020 | 309 | 0.130 |
Why?
| | Sex Factors | 4 | 2010 | 2104 | 0.120 |
Why?
| | Cell Phone | 1 | 2017 | 82 | 0.120 |
Why?
| | Family Characteristics | 4 | 2021 | 198 | 0.120 |
Why?
| | Biomarkers | 3 | 2025 | 4261 | 0.120 |
Why?
| | Mental Disorders | 1 | 2025 | 1154 | 0.120 |
Why?
| | Micronutrients | 2 | 2007 | 101 | 0.120 |
Why?
| | Urban Population | 1 | 2019 | 493 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 530 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3414 | 0.120 |
Why?
| | Fever | 1 | 2017 | 313 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2017 | 179 | 0.120 |
Why?
| | Health Resources | 1 | 2017 | 130 | 0.110 |
Why?
| | Feeding Methods | 1 | 2015 | 5 | 0.110 |
Why?
| | F2-Isoprostanes | 1 | 2015 | 20 | 0.110 |
Why?
| | Learning | 1 | 2020 | 448 | 0.110 |
Why?
| | Models, Psychological | 1 | 2017 | 297 | 0.110 |
Why?
| | Animals | 9 | 2026 | 37948 | 0.110 |
Why?
| | Methazolamide | 2 | 2005 | 5 | 0.110 |
Why?
| | Oxygen Isotopes | 2 | 2005 | 24 | 0.110 |
Why?
| | Acetazolamide | 2 | 2005 | 26 | 0.110 |
Why?
| | Histocytochemistry | 2 | 2005 | 78 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2015 | 58 | 0.110 |
Why?
| | Mobile Applications | 1 | 2017 | 197 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 522 | 0.110 |
Why?
| | Energy Intake | 2 | 2008 | 501 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1928 | 0.110 |
Why?
| | District of Columbia | 2 | 2012 | 37 | 0.110 |
Why?
| | Food Supply | 1 | 2015 | 85 | 0.100 |
Why?
| | Chickens | 2 | 2024 | 184 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 497 | 0.100 |
Why?
| | Age Factors | 5 | 2015 | 3329 | 0.100 |
Why?
| | Walking | 1 | 2018 | 542 | 0.100 |
Why?
| | Species Specificity | 2 | 2005 | 573 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2005 | 562 | 0.100 |
Why?
| | United States | 9 | 2021 | 16018 | 0.100 |
Why?
| | Health Behavior | 1 | 2019 | 786 | 0.100 |
Why?
| | India | 2 | 2025 | 220 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2021 | 3603 | 0.090 |
Why?
| | Social Support | 1 | 2017 | 650 | 0.090 |
Why?
| | Seroconversion | 2 | 2023 | 48 | 0.090 |
Why?
| | Kenya | 2 | 2023 | 127 | 0.090 |
Why?
| | Contact Tracing | 1 | 2012 | 26 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 342 | 0.090 |
Why?
| | Psychometrics | 3 | 2021 | 731 | 0.090 |
Why?
| | Transportation | 1 | 2012 | 55 | 0.090 |
Why?
| | Personal Protective Equipment | 2 | 2022 | 57 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2019 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 881 | 0.090 |
Why?
| | Insulin | 2 | 2015 | 2502 | 0.090 |
Why?
| | Mass Spectrometry | 2 | 2005 | 743 | 0.090 |
Why?
| | Quality Improvement | 4 | 2022 | 1287 | 0.080 |
Why?
| | Cattle | 1 | 2014 | 975 | 0.080 |
Why?
| | Area Under Curve | 2 | 2009 | 329 | 0.080 |
Why?
| | HLA Antigens | 2 | 2013 | 235 | 0.080 |
Why?
| | Acute Disease | 3 | 2019 | 1029 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2012 | 131 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 587 | 0.080 |
Why?
| | Nutrition Surveys | 4 | 2015 | 280 | 0.080 |
Why?
| | ROC Curve | 2 | 2009 | 618 | 0.080 |
Why?
| | Fetal Weight | 1 | 2009 | 53 | 0.080 |
Why?
| | Pilot Projects | 2 | 2025 | 1886 | 0.070 |
Why?
| | Chikungunya Fever | 2 | 2021 | 82 | 0.070 |
Why?
| | Quality of Life | 2 | 2022 | 3183 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2017 | 1148 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 337 | 0.070 |
Why?
| | Colorado | 3 | 2026 | 4558 | 0.070 |
Why?
| | Solanum tuberosum | 1 | 2008 | 8 | 0.070 |
Why?
| | HIV Infections | 1 | 2023 | 3148 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2022 | 17149 | 0.070 |
Why?
| | Edible Grain | 1 | 2008 | 48 | 0.070 |
Why?
| | Bias | 1 | 2009 | 197 | 0.070 |
Why?
| | Pregnancy in Diabetics | 1 | 2009 | 121 | 0.070 |
Why?
| | Middle Aged | 8 | 2025 | 35971 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2009 | 177 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2013 | 686 | 0.060 |
Why?
| | Radiographic Image Enhancement | 1 | 2007 | 57 | 0.060 |
Why?
| | Self Disclosure | 1 | 2007 | 62 | 0.060 |
Why?
| | Vegetables | 1 | 2008 | 162 | 0.060 |
Why?
| | Birth Weight | 1 | 2009 | 506 | 0.060 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2942 | 0.060 |
Why?
| | Vitamins | 2 | 2024 | 176 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2010 | 1103 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2137 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 980 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2007 | 427 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1537 | 0.060 |
Why?
| | Glucagon-Like Peptide 2 | 1 | 2025 | 7 | 0.060 |
Why?
| | Mammography | 1 | 2007 | 166 | 0.060 |
Why?
| | Weight Gain | 1 | 2009 | 557 | 0.060 |
Why?
| | Mental Health | 2 | 2023 | 792 | 0.060 |
Why?
| | Risk | 2 | 2021 | 911 | 0.060 |
Why?
| | West Nile Fever | 1 | 2026 | 57 | 0.060 |
Why?
| | Students | 2 | 2023 | 657 | 0.060 |
Why?
| | Influenza B virus | 1 | 2025 | 47 | 0.060 |
Why?
| | Anaplasma | 1 | 2024 | 3 | 0.060 |
Why?
| | Ehrlichia | 1 | 2024 | 4 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2013 | 2350 | 0.060 |
Why?
| | Bartonella | 1 | 2024 | 8 | 0.060 |
Why?
| | Rickettsia | 1 | 2024 | 11 | 0.060 |
Why?
| | Siphonaptera | 1 | 2024 | 14 | 0.050 |
Why?
| | Mental Recall | 1 | 2007 | 222 | 0.050 |
Why?
| | Dietary Fats | 1 | 2007 | 308 | 0.050 |
Why?
| | Ticks | 1 | 2024 | 30 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1134 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 2007 | 227 | 0.050 |
Why?
| | Cats | 1 | 2024 | 228 | 0.050 |
Why?
| | Influenza A virus | 1 | 2025 | 114 | 0.050 |
Why?
| | Nutritional Status | 1 | 2007 | 351 | 0.050 |
Why?
| | Prognosis | 1 | 2013 | 4312 | 0.050 |
Why?
| | Dog Diseases | 1 | 2024 | 70 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 729 | 0.050 |
Why?
| | Mosquito Vectors | 1 | 2023 | 29 | 0.050 |
Why?
| | Magnesium | 1 | 2024 | 155 | 0.050 |
Why?
| | Dogs | 1 | 2024 | 438 | 0.050 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2009 | 641 | 0.050 |
Why?
| | Larva | 1 | 2004 | 245 | 0.050 |
Why?
| | Databases, Factual | 2 | 2019 | 1494 | 0.050 |
Why?
| | Pyridoxine | 1 | 2022 | 37 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2023 | 8284 | 0.050 |
Why?
| | Vomiting | 1 | 2023 | 131 | 0.050 |
Why?
| | Cough | 1 | 2023 | 123 | 0.050 |
Why?
| | Vital Signs | 1 | 2022 | 48 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 131 | 0.040 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2022 | 99 | 0.040 |
Why?
| | Swine | 1 | 2024 | 828 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 296 | 0.040 |
Why?
| | World Health Organization | 1 | 2022 | 104 | 0.040 |
Why?
| | Fermentation | 1 | 2021 | 32 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 315 | 0.040 |
Why?
| | Phenotype | 2 | 2022 | 3147 | 0.040 |
Why?
| | Food Contamination | 1 | 2021 | 55 | 0.040 |
Why?
| | Methylene Blue | 1 | 2021 | 24 | 0.040 |
Why?
| | Equipment Reuse | 1 | 2021 | 18 | 0.040 |
Why?
| | Decontamination | 1 | 2021 | 31 | 0.040 |
Why?
| | Immunization | 1 | 2023 | 374 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 260 | 0.040 |
Why?
| | Hospitalization | 2 | 2022 | 2446 | 0.040 |
Why?
| | Hot Temperature | 1 | 2024 | 410 | 0.040 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2021 | 50 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 176 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 130 | 0.040 |
Why?
| | Brazil | 1 | 2021 | 182 | 0.040 |
Why?
| | Lead | 1 | 2021 | 70 | 0.040 |
Why?
| | Diet Surveys | 2 | 2013 | 90 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 281 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 516 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 52 | 0.040 |
Why?
| | Translations | 1 | 2020 | 18 | 0.040 |
Why?
| | Mass Screening | 1 | 2009 | 1348 | 0.040 |
Why?
| | Chikungunya virus | 1 | 2021 | 81 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 175 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2021 | 175 | 0.040 |
Why?
| | Parity | 1 | 2019 | 108 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 306 | 0.040 |
Why?
| | Child Language | 1 | 2019 | 21 | 0.040 |
Why?
| | Translating | 1 | 2019 | 50 | 0.040 |
Why?
| | Triage | 1 | 2021 | 249 | 0.040 |
Why?
| | Rural Health | 1 | 2019 | 87 | 0.040 |
Why?
| | Parasites | 1 | 2019 | 44 | 0.040 |
Why?
| | Dengue Vaccines | 1 | 2018 | 11 | 0.040 |
Why?
| | Arboviruses | 1 | 2018 | 14 | 0.040 |
Why?
| | Culturally Competent Care | 1 | 2019 | 73 | 0.030 |
Why?
| | Thinness | 1 | 2019 | 98 | 0.030 |
Why?
| | RNA, Viral | 1 | 2022 | 689 | 0.030 |
Why?
| | Seasons | 1 | 2021 | 556 | 0.030 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 82 | 0.030 |
Why?
| | Blood Glucose | 1 | 2008 | 2326 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 524 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 115 | 0.030 |
Why?
| | Proteins | 1 | 2004 | 1016 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 242 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1668 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2019 | 175 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 179 | 0.030 |
Why?
| | Mothers | 1 | 2023 | 765 | 0.030 |
Why?
| | Child Health | 1 | 2019 | 153 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 473 | 0.030 |
Why?
| | Medical Records | 1 | 2018 | 191 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 479 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 517 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2021 | 607 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 74 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1033 | 0.030 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.030 |
Why?
| | Research Design | 1 | 2023 | 1129 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2117 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2114 | 0.030 |
Why?
| | Risk-Taking | 1 | 2019 | 324 | 0.030 |
Why?
| | Aged | 3 | 2025 | 25955 | 0.030 |
Why?
| | Life Change Events | 1 | 2017 | 147 | 0.030 |
Why?
| | Telemedicine | 1 | 2025 | 957 | 0.030 |
Why?
| | Data Collection | 1 | 2018 | 635 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 695 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 99 | 0.030 |
Why?
| | Cities | 1 | 2015 | 143 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2365 | 0.030 |
Why?
| | Cognition | 1 | 2022 | 1263 | 0.030 |
Why?
| | Bacteria | 1 | 2019 | 894 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7140 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 332 | 0.020 |
Why?
| | Health Promotion | 1 | 2019 | 771 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2922 | 0.020 |
Why?
| | Automobiles | 1 | 2012 | 18 | 0.020 |
Why?
| | Virginia | 1 | 2012 | 55 | 0.020 |
Why?
| | Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 67 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 369 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1370 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1652 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3729 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 718 | 0.020 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 96 | 0.020 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2007 | 47 | 0.020 |
Why?
| | Environmental Exposure | 1 | 2012 | 574 | 0.020 |
Why?
| | Carotenoids | 1 | 2007 | 48 | 0.020 |
Why?
| | Research Personnel | 1 | 2009 | 185 | 0.020 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2007 | 154 | 0.010 |
Why?
| | Models, Statistical | 1 | 2009 | 677 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2009 | 461 | 0.010 |
Why?
| | Early Detection of Cancer | 1 | 2009 | 472 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2007 | 1056 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|